MPS II

E950113

MPS II, also known as Hunter syndrome, is a rare X-linked lysosomal storage disorder caused by iduronate-2-sulfatase deficiency, leading to progressive multi-organ dysfunction and developmental impairment.

Jump to: Statements Referenced by

Statements (52)

Predicate Object
instanceOf X-linked genetic disorder
lysosomal storage disease
mucopolysaccharidosis
rare disease
hasAlternativeName Hunter syndrome NERFINISHED
Mucopolysaccharidosis type II NERFINISHED
hasCause iduronate-2-sulfatase deficiency
hasChromosomalLocation Xq28
hasClinicalFeature airway obstruction
behavioral problems
cardiac valve disease
cardiomyopathy
coarse facial features
dysostosis multiplex
hearing loss
hepatosplenomegaly
inguinal hernia
intellectual disability
joint stiffness
progressive developmental delay
recurrent ear infections
short stature
sleep apnea
spinal canal stenosis
umbilical hernia
hasComplication neurological deterioration
progressive cardiac disease
progressive respiratory failure
hasDiagnosticTest measurement of iduronate-2-sulfatase activity
molecular genetic testing of IDS gene
urinary glycosaminoglycan analysis
hasEpidemiology ultra-rare disorder
hasGeneSymbol IDS NERFINISHED
hasInheritancePattern X-linked recessive
hasManagement multidisciplinary care
hasOnset childhood
hasPathophysiology accumulation of glycosaminoglycans
impaired degradation of dermatan sulfate
impaired degradation of heparan sulfate
hasSubtypes attenuated form
severe form
hasTreatment enzyme replacement therapy
idursulfase
idursulfase beta NERFINISHED
hasTreatmentGoal improve organ function
reduce glycosaminoglycan accumulation
isEncodedByGene IDS gene NERFINISHED
isListedIn OMIM:309900
Orphanet:558
isMoreCommonIn males
isNamedAfter Charles Hunter NERFINISHED
isRareIn females

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.